Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial

      Abstract

      Introduction

      The use of peppermint oil in treating the irritable bowel syndrome has been studied with variable results probably due to the presence of patients affected by small intestinal bacterial overgrowth, lactose intolerance or celiac disease that may have symptoms similar to irritable bowel syndrome.

      Aim

      The aim of the study was to test the effectiveness of enteric-coated peppermint oil in patients with irritable bowel syndrome in whom small intestinal bacterial overgrowth, lactose intolerance and celiac disease were excluded.

      Methods

      Fifty-seven patients with irritable bowel syndrome according to the Rome II criteria, with normal lactose and lactulose breath tests and negative antibody screening for celiac disease, were treated with peppermint oil (two enteric-coated capsules twice per day or placebo) for 4 weeks in a double blind study. The symptoms were assessed before therapy (T 0), after the first 4 weeks of therapy (T 4) and 4 weeks after the end of therapy (T 8). The symptoms evaluated were: abdominal bloating, abdominal pain or discomfort, diarrhoea, constipation, feeling of incomplete evacuation, pain at defecation, passage of gas or mucus and urgency at defecation. For each symptom intensity and frequency from 0 to 4 were scored. The total irritable bowel syndrome symptoms score was also calculated as the mean value of the sum of the average of the intensity and frequency scores of each symptom.

      Results

      At T 4, 75% of the patients in the peppermint oil group showed a >50% reduction of basal (T 0) total irritable bowel syndrome symptoms score compared with 38% in the placebo group ( P < 0.009). With peppermint oil at T 4 and at T 8 compared with T 0 a statistically significant reduction of the total irritable bowel syndrome symptoms score was found (T 0: 2.19 ± 0.13, T 4: 1.07 ± 0.10*, T 8: 1.60 ± 0.10*, * P < 0.01 compared with T 0, mean ± S.E.M.), while no change was found with the placebo.

      Conclusion

      A 4 weeks treatment with peppermint oil improves abdominal symptoms in patients with irritable bowel syndrome.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Thompson W.G.
        • Longstreth G.F.
        • Drossman D.A.
        • Heaton K.W.
        • Irvine E.J.
        • Müller-Lissner S.A.
        Functional bowel disorders and functional abdominal pain.
        Gut. 1999; 45: 43-47
        • Frissora C.L.
        • Koch K.L.
        Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.
        Curr Gastroenterol Rep. 2005; 7: 264-271
        • Lin H.C.
        Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome.
        J Am Med Assoc. 2004; 292: 852-858
        • Pimentel M.
        • Kong Y.
        • Park S.
        Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption.
        Am J Gastroenterol. 2003; 98: 2700-2704
        • Vernia P.
        • Di Camillo M.
        • Marinaro V.
        Lactose malabsorption, irritable bowel syndrome and self-reported milk intolerance.
        Dig Liver Dis. 2001; 33: 234-239
        • Ojetti V.
        • Nucera G.
        • Migneco A.
        • Gabrielli M.
        • Lauritano C.
        • Danese S.
        • et al.
        High prevalence of celiac disease in patients with lactose intolerance.
        Digestion. 2005; 71: 106-110
        • De Giorgio R.
        • Barbara G.
        • Stanghellini V.
        • Cremon C.
        • Salvioli B.
        • De Ponti F.
        • et al.
        Diagnosis and therapy of irritable bowel syndrome.
        Aliment Pharmacol Ther. 2004; 20: 10-22
        • Kline R.M.
        • Kline J.J.
        • Di Palma J.
        • Barbero G.J.
        Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
        J Pediatr. 2001; 138: 125-128
        • Liu J.H.
        • Chen G.H.
        • Yeh H.Z.
        • Huang C.K.
        • Poon S.K.
        Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.
        J Gastroenterol. 1997; 32: 765-768
        • Pittler M.H.
        • Ernst E.
        Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.
        Am J Gastroenterol. 1998; 93: 1131-1135
        • Ringel Y.
        • Sperber A.D.
        • Drossman D.A.
        Irritable bowel syndrome.
        Annu Rev Med. 2001; 52: 319-338
        • Lesbros-Pantoflickova D.
        • Michetti P.
        • Fried M.
        • Beglinger C.
        • Blum A.L.
        Meta-analysis: the treatment of irritable bowel syndrome.
        Aliment Pharmacol Ther. 2004; 20: 1253-1269
        • Hussain Z.
        • Quigley E.M.
        Systematic review: complementary and alternative medicine in the irritable bowel syndrome.
        Aliment Pharmacol Ther. 2006; 23: 465-471
        • Nash P.
        • Gould S.R.
        • Bernardo D.E.
        Peppermint oil does not relieve the pain of irritable bowel syndrome.
        Br J Clin Pract. 1986; 40: 292-293
        • Carling I.
        • Svedberg L.E.
        • Hulten S.
        Short term treatment of the irritable bowel syndrome: a placebo-controlled trial of peppermint oil against hyoschamine.
        OPMEAR. 1989; 34: 55-57
        • Dew M.J.
        • Evans B.K.
        • Rhodes J.
        Peppermint oil for the irritable bowel syndrome: a multicentre trial.
        Br J Clin Pract. 1984; 38: 394-398
        • Lech Y.
        • Olesen K.M.
        • Hey H.
        • Rask-Pedersen E.
        • Vilien M.
        • Ostergaard O.
        Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo.
        Ugeskr Laeger. 1988; 150: 2388-2389
        • Rees W.D.
        • Evans B.K.
        • Rhodes J.
        Treating irritable bowel syndrome with peppermint oil.
        Br Med J. 1979; 6194: 835-836
        • Farup P.G.
        • Monsbakken K.W.
        • Vandvik P.O.
        Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study.
        Scand J Gastroenterol. 2004; 39: 645-649
        • Peralta S.
        • Petta S.
        • Venezia G.
        • Bellia U.
        • Cammà C.
        • Craxì A.
        Small intestinal bacterial overgrowth: a new face of irritable bowel syndrome?.
        Dig Liver Dis. 2006; 38: S203
        • Hills J.M.
        • Aaronson P.I.
        The mechanism of action of peppermint oil on gastrointestinal smooth muscle.
        Gastroenterology. 1991; 101: 55-65
        • Grigoleit H.G.
        • Grigoleit P.
        Gastrointestinal clinical pharmacology of peppermint oil.
        Phytomedicine. 2005; 12: 607-611
        • Snape Jr., W.J.
        Role of colonic motility in guiding therapy in patients with constipation.
        Dig Dis. 1997; 15: 104-111
        • Nobaek S.
        • Johansson M.L.
        • Molin G.
        • Ahrne S.
        • Jeppsson B.
        Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
        Am J Gastroenterol. 2000; 95: 1231-1238
        • Pimentel M.
        • Mayer A.G.
        • Park S.
        • Chow E.J.
        • Hasan A.
        • Kong Y.
        Methane production during lactulose breath test is associated with gastrointestinal disease presentation.
        Dig Dis Sci. 2003; 48: 86-92
        • Logan A.C.
        • Beaulne T.M.
        The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report.
        Altern Med Rev. 2002; 7: 410-417
        • Whorwell P.J.
        • Altringer L.
        • Morel J.
        • Bond Y.
        • Charbonneau D.
        • O’Mahony L.
        • et al.
        Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
        Am J Gastroenterol. 2006; 101: 1581-1590
        • Santos Ocampo P.D.
        • Bravo L.C.
        • Rogacion J.M.
        • Battad G.R.
        A randomized double-blind clinical trial of a maltodextrin-containing oral rehydration solution in acute infantile diarrhea.
        J Pediatr Gastroenterol Nutr. 1993; 16: 23-28